AC Immune S.A. (ACIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2006 | 12-2005 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 79,644 | N/A | N/A |
| Receivables | 280 | N/A | N/A |
| Other current assets | 49 | 0 | 0 |
| TOTAL | $82,583 | $N/A | $N/A |
| Non-Current Assets | |||
| PPE Net | 520 | N/A | N/A |
| Investments And Advances | 89 | 0 | 0 |
| TOTAL | $609 | $N/A | $N/A |
| Total Assets | $83,192 | $N/A | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 1,789 | 0 | 0 |
| Accrued Expenses | 4,514 | N/A | N/A |
| TOTAL | $6,350 | $N/A | $N/A |
| Non-Current Liabilities | |||
| Deferred Revenues | 47 | N/A | N/A |
| Other Non-Current Liabilities | 2,901 | 0 | 0 |
| TOTAL | $2,901 | $N/A | $N/A |
| Total Liabilities | $9,251 | $N/A | $N/A |
| Shareholders' Equity | |||
| Common Shares | 966 | N/A | N/A |
| Retained earnings | -42,029 | N/A | N/A |
| TOTAL | $73,942 | $N/A | $N/A |
| Total Liabilities And Equity | $83,192 | $0 | $0 |